Icahn School Of Medicine At Mount Sinai insider trades
Icahn School Of Medicine At Mount Sinai has filed 4 Form 4s with the SEC that we hold, for GeneDx Holdings Corp. (WGS) (10% owner) and Renalytix plc (RNLX) (10% owner). Across all of them we count 1 purchase worth $25.0M and 3 sales worth $75.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 865,800 shares of GeneDx Holdings Corp. worth $64.9M, dated 2024-10-31. The first filing on our record is dated 2022-05-05 and the latest 2024-11-19.
GeneDx Holdings Corp. (WGS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-29 | P, purchase reported on Form 4 | 6,250,000 | $25.0M | 2022-05-05 |
| 2024-10-31 | S, sale reported on Form 4 | 865,800 | $64.9M | 2024-11-04 |
| 2024-11-15 | S, sale reported on Form 4 | 20,359 | $1.4M | 2024-11-19 |
| 2024-11-18 | S, sale reported on Form 4 | 126,782 | $9.0M | 2024-11-19 |
Renalytix plc (RNLX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1883139) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms